Authors: KRACK P DEUSCHL G BENECKE R CEBALLOSBAUMANN AO MARION MH OERTEL WH POEWE W

Citation: P. Krack et al., DOSE STANDARDIZATION OF BOTULINUM TOXIN, Movement disorders, 13(4), 1998, pp. 749-750

Authors: MARION MH KRACK P

Citation: Mh. Marion et P. Krack, APRAXIA OF LID OPENING - REPLY, Movement disorders, 10(5), 1995, pp. 687-687

Authors: MARION MH SHEEHY M SANGLA S SOULAYROL S

Citation: Mh. Marion et al., DOSE STANDARDIZATION OF BOTULINUM TOXIN, Journal of Neurology, Neurosurgery and Psychiatry, 59(1), 1995, pp. 102-103

Authors: KRACK P MARION MH

Citation: P. Krack et Mh. Marion, APRAXIA OF LID OPENING, A FOCAL EYELID DYSTONIA - CLINICAL-STUDY OF 32 PATIENTS, Movement disorders, 9(6), 1994, pp. 610-615

Authors: KRACK P MARION MH

Citation: P. Krack et Mh. Marion, APRAXIA OF LID OPENING, A FOCAL EYELID DYSTONIA - CLINICAL-STUDY OF 32 PATIENTS, Movement disorders, 9(6), 1994, pp. 610-615

Authors: ALICHERIF A ALLAIN H BRUNETBOURGIN F PINEL JF BARROCHE G CHAZOT G BROUSSOLLE E DURIF F GUILLARD A FENELON G HENRY G DECOMBE R DUQUENOY F MARION MH MIHOUT B MORELMAROGER A FERROIR JP PETIT H DELISSE B VERMERSCH P POLLAK P ZIEGLER M NEUKIRCH HC COUGNARD J

Citation: A. Alicherif et al., MONOTHERAPY SELEGILINE TRIAL IN DE-NOVO P ARKINSONIAN-PATIENTS, Therapie, 48(3), 1993, pp. 225-231